India  

Corbevax

Vaccine against COVID-19

Corbevax    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Corbevax: Vaccine against COVID-19
Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. It is licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.

0
shares
ShareTweetSavePostSend
 

You Might Like


Speed up Covid booster dose drive: Centre

​​He also asked states and UTs to widely publicise the availability of heterologous precaution dose of Corbevax vaccine and organise vaccination camps at public places such as railway stations,..
IndiaTimes - Published

Corbevax likely to be available at vaccination centres from today, know price, features, other details

Corbevax is the first Indian vaccine to be approved as heterologous COVID-19 booster dose. It uses a traditional recombinant protein-based technology.
DNA - Published

100 million doses of Corbevax supplied to Centre: Biological E Ltd

In a release, the city-based vaccine maker said, “Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India till now. Pan-India roll-out of Corbevax in children 12-14..
IndiaTimes - Published

Corbevax gets nod as booster after Covishield, Covaxin shots


IndiaTimes - Published

Corbevax available as booster dose from August 12: Here's how to book a slot

Corbevax will be available as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose.
DNA - Published

India to start Covid mix-and-match booster vaccines on Friday

India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's..
IndiaTimes - Published

Biological E's Corbevax approved as booster dose for adults vaccinated with Covaxin, Covishield

This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed in India.
DNA - Published Also reported by •IndiaTimes

Corbevax Covid booster expected to get final approval from government soon: Report

Earlier on June 4, DCGI approved Corbevax as a precaution dose for those aged 18 and above.
DNA - Published

Govt nod for Corbevax as booster for adults vaccinated with Covishield, Covaxin soon


IndiaTimes - Published

Biological E's Corbevax, Bharat Biotech's Covaxin get NTAGI's nod for use children aged 5-12 years

Prime Minister Narendra Modi emphasised that all eligible children get the Covid-19 vaccine as soon as possible via "special programmes" in schools.
DNA - Published

NTAGI approves Corbevax, Covaxin for 5-12 years age group: Sources


IndiaTimes - Published

Corbevax being considered as booster dose for Covishield, Covaxin jabbed people

NTAGI is considering using Corbevax as a booster vaccination against Covid-19.
DNA - Published

NTAGI nod due, wait continues for Corbevax as booster dose

Biological E’s Corbevax vaccine, which was recently approved by the chief drug regulatory body of India to be used as a booster dose, may take a while to arrive at vaccination centres. The reason:..
IndiaTimes - Published

NTAGI to discuss allowing Corbevax as booster shot for Covishield, Covaxin recipients: Sources

Allowing Biological E's Corbevax as a booster for those fully vaccinated against Covid-19 with either Covishield or Covaxin and reducing the gap between the second dose and the precaution dose of the..
IndiaTimes - Published

Biological E has delivered 100m Corbevax doses so far


IndiaTimes - Published

DCGI clears Corbevax as Covid booster shot for those aged 18 and above

In April, DCGI had given emergency use authorisation (EUA) to Corbevax for children between 5 and 12 years.
DNA - Published

Covid vaccination: Price of Corbevax dose reduced from Rs 840 to Rs 250

Corbevax is currently being administered to children in the age group of 12-14.
DNA - Published

Biological E slashes Corbevax price in private market to Rs 250 per dose

Biological E Limited (BE) on Monday said it is reducing the price of its Covid-19 vaccine Corbevax to Rs 250 per dose (inclusive of GST but excluding administration charges) from Rs 840 per dose..
IndiaTimes - Published

Corbevax maker seeks emergency use approval as booster jab for adults vaccinated with Covishield, Covaxin

There were 416 patients aged 18 to 80 who got two doses of Covaxin or Covishield, the last one six months before the Corbevax booster.
DNA - Published

Covid-19: Govt to expedite process of recognition of Biological E Corbevax

The government plans to expedite the process of recognition of COVID-19 vaccine Corbevax by other countries while its manufacturer Biological E pursues WHO's emergency use listing for the jab being..
IndiaTimes - Published

DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age group

The Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..
IndiaTimes - Published

Emergency use proposal for Corbevax among kids: How is it different from other Covid vaccines?

The vaccine has been developed in collaboration with Texas Children's Hospital Centre for Vaccine Development and Baylor College of Medicine, Houston.
DNA - Published

Covid vaccine: Govt panel recommends EUA for Biological E's Corbevax for 5 to 11 years


IndiaTimes - Published

Expert panel recommends Corbevax Covid jab for 5-12 years age group

Biological E’s Covid-19 vaccine, Corbevax, is likely to get an emergency-use authorisation (EUA) for use in children in the 5-12 years age bracket following recommendations from the subject expert..
IndiaTimes - Published

Hyderabad's Biological E to get mRNA technology from WHO to produce Covid-19 vaccines

Biological E Limited (BE), the Hyderabad-based vaccine maker that has developed a recombinant sub-unit protein vaccine Corbevax for Covid-19, has now been selected as a recipient of mRNA technology..
IndiaTimes - Published

SII's Covovax becomes the fourth jab to be used for vaccination of 12-17 age group

Covovax is the 4th Covid vaccine authorised for administration in 12 years and above after ZyCoV-D, Bharat Biotech's Covaxin, Biological E's Corbevax.
DNA - Published

Over 1 crore children 12-14 years age-group administered Covid vaccine first dose: Mansukh Mandaviya

The vaccination for this age group started on March 16 with Biological E's intramuscular vaccine Corbevax, two doses of which are to be administered 28 days apart. As of March 1 last year, there were..
IndiaTimes - Published

Over 2.6 lakh doses of Covid vaccine 'Corbevax' administered to children aged 12-14 years


IndiaTimes - Published

Biological E’s Corbevax to cost Rs 990 per jab in private market, price for govt supplies at Rs 145/dose

Vaccine maker Biological E (BE) on Wednesday announced the pricing of Rs 990 per dose, including taxes and administration charges, for its recombinant protein sub-unit vaccine Corbevax in the private..
IndiaTimes - Published

Corbevax vaccine shot to cost Rs 990 in private market, Rs 145 at govt facilities


IndiaTimes - Published

Covid-19 vaccination for 12-14 age group starts today - Here's how you can book vaccination slot

Corbevax has been included as the third vaccine against Covid-19 and will be available at all centres where free vaccination is available.
DNA - Published

India to start vaccinating children aged 12-14 years from tomorrow, only Corbevax vaccine to be used


IndiaTimes - Published

Corbevax - 10 points about India's first RBD protein Covid vaccine for 12-14 years

Corbevax is administered intramuscularly. Two doses are given at an interval of 28 days. It's the cheapest vaccine with cost of 2 doses below Rs 400.
DNA - Published

Covid vaccination for kids aged 12-14 to start tomorrow

The government has lowered the age for Covid vaccination to 12 years, a move that is expected to relieve many parents ahead of the new academic session that starts from April. Vaccination for..
IndiaTimes - Published

Covid-19 vaccination drive for children aged 12-14 to start this week, say official sources

Children in the age group 12-14 will be administered Biological E's Corbevax vaccine.
DNA - Published

Biological E seeks EUA for Covid vaccine Corbevax for children in 5-12 age group: Official sources

Recently, the subject expert committee recommended emergency use authorization (EUA) for Biological E's Covid-19 vaccine Corbevax for the age group of 12 to 18 years under certain conditions. The drugs..
IndiaTimes - Published

Corbevax gets emergency use nod for 12-18 age group

Hyderabad-based pharmaceutical company Biological E Ltd has received an emergency use approval from Drugs Controller General of India for use in children aged 12 to 18 years
IndiaTimes - Published

Covid: Third vaccine available for 12-17 age group as Corbevax gets nod

The nation’s drug regulator has authorised vaccine-maker Biological E’s Corbevax for emergency use among children in the 12-17 age group, making a third shot available in the coronavirus..
IndiaTimes - Published

Covid: DCGI grants EUA to BE's Corbevax for use in kids aged 12-18 years

Vaccine maker Biological E Limited’s (BE), receptor binding domain (RBD) protein sub-unit Covid-19 vaccine Corbevax has bagged emergency use authorisation (EUA) from the Drugs Controller General of..
IndiaTimes - Published

Government may get 5 crore Corbevax doses in February, could jab 12-15-year group


IndiaTimes - Published

Corbevax gets nod, paves way to lower age bar for Covid jab

The drug regulator's expert committee on Monday recommended emergency approval to Biological E's Covid vaccine Corbevax for use in adolescents of 12-18 years, a move that is likely to pave the way for..
IndiaTimes - Published

Corbevax Covid-19 vaccine recommended for emergency use in 12-18 years age group

The Drugs Controller General Of India (DCGI) has already approved Corbevax for restricted use in emergency situation in adults on December 28.
DNA - Published

Experts group to decide on Corbevax vaccine approval for 12-18 age group today

The drug regulator’s subject expert committee will meet on Monday to evaluate Biological E’s application seeking emergency approval for its Covid vaccine Corbevax to be used in youngsters of 12-18..
IndiaTimes - Published

Experts' call today on Corbevax for 12-18 age group


IndiaTimes - Published

Government orders 5 crore Corbevax doses, may go to U-15 kids

The government has placed a purchase order with Biological E for five crore doses of its Covid vaccine Corbevax, which are expected to arrive by the end of February and boost the availability of jabs..
IndiaTimes - Published

‘Corbevax can be booster, many countries also need primary vaccination’


IndiaTimes - Published

Discussions underway for WHO approval for Corbevax Covid-19 vaccine, says developer

Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by the Indian government and will be manufactured by the..
IndiaTimes - Published

Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose

Biological E, Hyderabad-based pharmaceutical company on Tuesday received the emergency-use authorisation for manufacturing and marketing of Corbevax.
DNA - Published

India approves Corbevax, Covovax vaccines for emergency use


IndiaTimes - Published

Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nod

In a significant boost for India’s fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines – Corbevax..
IndiaTimes - Published


 Page 1  〉